09:55 AM EST - Satellos Bioscience Inc. : Announced today that Frank Gleeson, Co-founder and CEO will participate in Oppenheimer’s Movers in Rare Disease Summit taking place in New York City on December 12. Satellos Bioscience Inc.
shares T.MSCL are trading unchanged at $0.71.
